Value of 1-alpha-hydroxy vitamin D3 in treatment of primary hyperparathyroidism before parathyroidectomy.Br Med J 1979; 1 doi: http://dx.doi.org/10.1136/bmj.1.6161.450 (Published 17 February 1979) Cite this as: Br Med J 1979;1:450
- D A Heath,
- W Van't Hoff,
- A D Barnes,
- J G Gray
The postoperative course of six patients with primary hyperparathyroidism and obvious radiological evidence of bone disease pretreated with 1-alpha-hydroxy vitamin D3 (1 alpha HCC) was indistinguishable from that of six patients with a similar clinical and radiological picture who were not pretreated. 1alphaHCC may increase the hypercalcaemia in some cases and cannot be recommended for the routine preparation of such patients for surgery.